Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer

Tobacco is a known risk factor for lung cancer, and continued tobacco use is associated with poorer outcomes across multiple lung cancer treatment modalities including surgery, chemotherapy and radiation therapy. Less is known about the association of tobacco use and outcomes with immune checkpoint...

Full description

Bibliographic Details
Main Authors: Lucy K. Corke, Janice J. N. Li, Natasha B. Leighl, Lawson Eng
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/9/492